Efficacy of Goshajinkigan for Oxaliplatin-Induced Peripheral Neuropathy in Colorectal Cancer Patients

Table 4

Adverse events of grades 3 and 4 observed in the GJG and non-GJG groups receiving oxaliplatin-based chemotherapy.

	GJG group; N = 29	Non-GJG group; N = 44
General fatigue	0	4/44, 9.0%
Allergic reaction	0	1/44, 2.2%
Oral mucositis	2/29, 6.9%	1/44, 2.2%
Disorder of blood	3/29, 10.3%	4/44, 9.0%
Infection	1/29, 3.4%	4/44, 9.0%
Nausea and vomiting	4/29, 13.7%	7/44, 15.9%
Diarrhea	2/29, 6.9%	3/44, 6.8%
Hand-foot syndrome	0	1/44, 2.2%
Pain	1/29, 3.4%	2/44, 4.5%
Peripheral neuropathy	2/29, 6.9%	15/44, 34.0%